Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,810 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial.
Lavole A, Mazieres J, Schneider S, Brosseau S, Kiakouama L, Greillier L, Guihot A, Abbar B, Baron M, Makinson A, Langlais A, Morin F, Spano JP, Cadranel J; On behalf the French Cooperative Thoracic Intergroup (IFCT). Lavole A, et al. Among authors: baron m. Lung Cancer. 2021 Aug;158:146-150. doi: 10.1016/j.lungcan.2021.05.031. Epub 2021 May 28. Lung Cancer. 2021. PMID: 34217967 Clinical Trial.
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations.
Bouzidi A, Labreche K, Baron M, Veyri M, Denis JA, Touat M, Sanson M, Davi F, Guillerm E, Jouannet S, Charlotte F, Bielle F, Choquet S, Boëlle PY, Cadranel J, Leblond V, Autran B, Lacorte JM, Spano JP, Coulet F; IDEATION study group. Bouzidi A, et al. Among authors: baron m. Front Cell Dev Biol. 2021 Aug 3;9:661272. doi: 10.3389/fcell.2021.661272. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34710202 Free PMC article.
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer.
Baron M, Soulié C, Lavolé A, Assoumou L, Abbar B, Fouquet B, Rousseau A, Veyri M, Samri A, Makinson A, Choquet S, Mazières J, Brosseau S, Autran B, Costagliola D, Katlama C, Cadranel J, Marcelin AG, Lambotte O, Spano JP, Guihot A, The French Cooperative Thoracic Intergroup Ifct Chiva-Investigators, The Anrs Co OncoVIHAC Study Group. Baron M, et al. Cells. 2022 Mar 17;11(6):1015. doi: 10.3390/cells11061015. Cells. 2022. PMID: 35326466 Free PMC article.
Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells.
Gazzano M, Parizot C, Psimaras D, Vozy A, Baron M, Abbar B, Fallet V, Litvinova E, Canellas A, Birzu C, Pourcher V, Touat M, Weiss N, Demeret S, Roos-Weil D, Spano JP, Lebbe C, Salem JE, Cadranel J, Hervier B, Gorochov G, Guihot A. Gazzano M, et al. Among authors: baron m. Front Immunol. 2022 Dec 20;13:1082084. doi: 10.3389/fimmu.2022.1082084. eCollection 2022. Front Immunol. 2022. PMID: 36605194 Free PMC article.
CAR T-cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes.
Lacan C, Caron J, Tarantino N, Fouquet B, Cherai M, Parizot C, Morel V, Souchet L, Uzunov M, Gorochov G, Nguyen-Quoc S, Sourdeau E, Vieillard V, Miyara M, Vinit A, Solorzano S, Soussain C, Houillier C, Metz C, Autran B, Litvinova E, Le Garff-Tavernier M, Norol F, Roos-Weil D, Choquet S, Guihot A, Baron M. Lacan C, et al. Among authors: baron m. Haematologica. 2023 Dec 1;108(12):3485-3490. doi: 10.3324/haematol.2023.282875. Haematologica. 2023. PMID: 37345469 Free PMC article. No abstract available.
Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments.
Baron M, Labreche K, Veyri M, Désiré N, Bouzidi A, Seck-Thiam F, Charlotte F, Rousseau A, Morin V, Nakid-Cordero C, Abbar B, Picca A, Le Cann M, Balegroune N, Gauthier N, Theodorou I, Touat M, Morel V, Bielle F, Samri A, Alentorn A, Sanson M, Roos-Weil D, Haioun C, Poullot E, De Septenville AL, Davi F, Guihot A, Boelle PY, Leblond V, Coulet F, Spano JP, Choquet S, Autran B. Baron M, et al. Haematologica. 2024 Nov 1;109(11):3615-3630. doi: 10.3324/haematol.2023.284332. Haematologica. 2024. PMID: 38841782 Free PMC article.
Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study.
Assoumou L, Baldé R, Katlama C, Abbar B, Delobel P, Allegre T, Lavole A, Makinson A, Zaegel-Faucher O, Greillier L, Soulie C, Veyri M, Bertheau M, Algarte Genin M, Gibowski S, Marcelin AG, Bihan K, Baron M, Costagliola D, Lambotte O, Spano JP. Assoumou L, et al. Among authors: baron m. J Immunother Cancer. 2024 Aug 22;12(8):e009728. doi: 10.1136/jitc-2024-009728. J Immunother Cancer. 2024. PMID: 39179255 Free PMC article.
Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma.
Baron M, Belin L, Cassoux N, Fardeau C, Blaizeau M, Soussain C, Houillier C, Hoang-Xuan K, Gyan E, Le Lez ML, Lavaud A, Soubeyran P, Bodaghi B, Costopoulos M, Leblond V, Touitou V, Maloum K, Errera MH, Roos-Weil D, Le Garff-Tavernier M, Choquet S. Baron M, et al. Blood. 2020 May 14;135(20):1811-1815. doi: 10.1182/blood.2019003073. Blood. 2020. PMID: 32125361 Free article. No abstract available.
1,810 results